Adverum Biotechnologies, Inc.: capex
| Value | {"amount": 388000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | Adverum Biotechnologies, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:01:45.662009+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a0d37873-1d08-4343-961e-be7287cbdf56
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-25-017767Retrieved: 2026-08-19T15:01:45.662009+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001501756/capex/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a0d37873-1d08-4343-961e-be7287cbdf56
History
- no predecessors — first report